Nevertheless, in macrophages activation of Dll4/Notch3 has been associated with plaque instability (Figure 2) (132) and inhibition of Dll4-mediated Notch signaling in metabolic syndrome has proven to be effective in slowing down the progression of atherosclerosis (133). The gene discussed is DLL4; the disease is metabolic syndrome.